Vitiligo and systemic sclerosis: Are they associated?– Lessons from a population‐based study
Open Access
- 3 November 2022
- journal article
- research article
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 64 (1) , E65-E71
Abstract
Background: The epidemiological relationship of vitiligo with systemic sclerosis (SSc) remains to be precisely evaluated.Objective: To investigate the bidirectional association between vitiligo and SSc.Methods: A population‐based study was carried out to compare vitiligo patients (n = 20,851) with age‐, sex‐ and ethnicity‐matched control subjects (n = 102,475) regarding the incidence of new‐onset and the prevalence of preexisting SSc. Adjusted hazard ratios (HRs) and adjusted odds ratios (ORs) were calculated by the Cox regression and logistic regression, respectively.Results: The incidence rate of new‐onset SSc was calculated at 2.4 (95% CI, 1.6–3.4) and 0.4 (95% CI, 0.3–0.6) cases per 10,000 person‐years among patients with vitiligo and controls, respectively. Patients with vitiligo had an increased risk of SSc (fully adjusted HR, 5.37; 95% CI, 3.03–9.54; p < 0.001). Correspondingly, a history of SSc predicted elevated odds of developing vitiligo (fully adjusted OR, 2.09; 95% CI, 1.23–3.55; p = 0.006). Relative to other patients with vitiligo, those with vitiligo and comorbid SSc were older and had a higher prevalence of ischaemic heart disease, hyperlipidaemia, and hypertension.Conclusions: A robust bidirectional association exists between vitiligo and SSc. This knowledge is valuable for physicians managing patients with both conditions. Patients with vitiligo and comorbid SSc might be monitored for cardiovascular and metabolic comorbidities.Keywords
This publication has 20 references indexed in Scilit:
- Comorbidities in vitiligo: comprehensive reviewInternational Journal of Dermatology, 2018
- Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosisBest Practice & Research Clinical Rheumatology, 2018
- Precise role of dermal fibroblasts on melanocyte pigmentationJournal of Dermatological Science, 2017
- Autoimmune vitiligo in rheumatic disease in the mestizo Mexican populationBiomedical Reports, 2016
- Prevalence of Vitiligo and Associated Comorbidities in KoreaYonsei Medical Journal, 2015
- Key Regulatory Role of Dermal Fibroblasts in Pigmentation as Demonstrated Using a Reconstructed Skin Model: Impact of Photo-AgingPLOS ONE, 2014
- Current aspects of vitiligo geneticsAdvances in Dermatology and Allergology, 2014
- Six Decades of Vitiligo Genetics: Genome-Wide Studies Provide Insights into Autoimmune PathogenesisJournal of Investigative Dermatology, 2012
- Pseudovitiligo in systemic sclerosisDermatology Online Journal, 2005
- ON THE NEED FOR THE RARE DISEASE ASSUMPTION IN CASE-CONTROL STUDIESAmerican Journal of Epidemiology, 1982